
MOTS-c (10mg)
Peptides
€20.00
0Concentration:
10 mg
Volume:
5 vials
Buy MOTS-c 5 vials 10mg Peptides online. Premium peptide for fat metabolism, energy production, endurance, performance, and anti-aging.
Description
MOTS-c is a unique mitochondrial-derived peptide (MDP) encoded within the Mitochondrial ORF of the 12S rRNA. It plays a crucial role in cellular energy regulation, metabolic balance, and stress response. By enhancing insulin sensitivity, promoting glucose utilization, and improving mitochondrial function, MOTS-c is an exciting peptide for research into metabolic disorders, exercise performance, and longevity.
Why MOTS-c Stands Out
Unlike traditional peptides that originate from nuclear DNA, MOTS-c is encoded in mitochondrial DNA, linking it directly to energy production and cellular homeostasis. Research suggests it may help combat age-related metabolic decline, obesity, and insulin resistance:
Metabolic Regulation: Enhances glucose uptake and utilization
Mitochondrial Function: Supports energy production and stress adaptation
Longevity Potential: May contribute to healthy aging and metabolic resilience
Key Benefits of MOTS-c
✅ Improves insulin sensitivity & glucose metabolism
✅ Supports weight management and fat oxidation
✅ Enhances cellular energy production
✅ Promotes exercise endurance and recovery
✅ Potential role in healthy aging and longevity research
Application & Dosage Guidelines
Dosage Range (Research Use): 5 mg to 10 mg per week (varies by study)
Administration: Subcutaneous injection (research use only)
Frequency: 2–3 times per week (study dependent)
Reconstitution: Mix with bacteriostatic or sterile water for injection
Storage: Keep refrigerated after mixing (up to 10 days)
⚠️ Safety & Side Effects
All dosing information is for research purposes only and not for human consumption unless prescribed by a licensed medical professional. Possible dose-dependent effects may include:
Temporary fatigue or mild nausea
Hormonal or metabolic fluctuations
Rare digestive discomfort
Preclinical and clinical studies suggest MOTS-c may be a promising therapeutic candidate for type 2 diabetes, obesity, and age-related metabolic decline.